Acinetobacter Baumannii News and Research

RSS
BioMed Protect’s Sanotracin RTU rapidly and effectively kills C. difficile within 3 minutes

BioMed Protect’s Sanotracin RTU rapidly and effectively kills C. difficile within 3 minutes

New photoactive compound eradicates 'Iraqibacter' from wounds and skin infections

New photoactive compound eradicates 'Iraqibacter' from wounds and skin infections

Study finds multidrug-resistant Acinetobacter baumannii in 48% of infected patient rooms

Study finds multidrug-resistant Acinetobacter baumannii in 48% of infected patient rooms

Two TGen students receive SRP grants for antibiotic resistance and Alzheimer's research

Two TGen students receive SRP grants for antibiotic resistance and Alzheimer's research

ASM to honor LA BioMed investigator for A. baumannii infection study

ASM to honor LA BioMed investigator for A. baumannii infection study

Temple University, URMC partner to translate novel medical research into new drugs

Temple University, URMC partner to translate novel medical research into new drugs

Cubist initiates CXA-201 Phase 3 trial in complicated urinary tract infections

Cubist initiates CXA-201 Phase 3 trial in complicated urinary tract infections

Tetraphase presents TP-434, TP-2758 antibiotics study data against pathogens at ECCMID

Tetraphase presents TP-434, TP-2758 antibiotics study data against pathogens at ECCMID

New in vitro study results show that wound dressing with ionic silver kills strains of highly-resistant bacteria

New in vitro study results show that wound dressing with ionic silver kills strains of highly-resistant bacteria

IDSA develops plans to combat deadly antibiotic-resistant 'super bugs'

IDSA develops plans to combat deadly antibiotic-resistant 'super bugs'

Tru-D UV-C device effective in reducing pathogens on all environmental surfaces in hospital patient rooms

Tru-D UV-C device effective in reducing pathogens on all environmental surfaces in hospital patient rooms

Stratatech receives SBIR grant to develop anti-infective living human skin substitute

Stratatech receives SBIR grant to develop anti-infective living human skin substitute

NIAID announces four new contracts for clinical trials to address problem of antimicrobial resistance

NIAID announces four new contracts for clinical trials to address problem of antimicrobial resistance

NC State receives $1.8M defense grant to test molecule efficacy against antibiotic-resistant infections

NC State receives $1.8M defense grant to test molecule efficacy against antibiotic-resistant infections

New antibacterial peptide effective against infections in burn or blast wounds

New antibacterial peptide effective against infections in burn or blast wounds

Cubist Pharmaceuticals total net revenues for second-quarter 2010 increase 29%

Cubist Pharmaceuticals total net revenues for second-quarter 2010 increase 29%

Aggressive infection control measures stop spread of Acinetobacter baumannii at Dallas hospital

Aggressive infection control measures stop spread of Acinetobacter baumannii at Dallas hospital

Effective compound against antibiotic-resistant biofilms

Effective compound against antibiotic-resistant biofilms

Kenta Biotech and Rentschler Biotechnologie sign agreement to develop antibody against MRSA

Kenta Biotech and Rentschler Biotechnologie sign agreement to develop antibody against MRSA

U.S. army Phase I STTR contract for Intralytix

U.S. army Phase I STTR contract for Intralytix